Status:
COMPLETED
Influence of Ribavirin and Interferon on Semen Quality, IRIS Study
Lead Sponsor:
Foundation for Liver Research
Collaborating Sponsors:
Erasmus Medical Center
Conditions:
Sperm Motility (Focus of Study)
Eligibility:
MALE
18-70 years
Brief Summary
The aim of this study is to study the effect of peginterferon alpha and ribavirin on spermatozoa.
Detailed Description
During and six months after treatment with peginterferon alpha and ribavirin strict use of birth control is recommended (the producers advice two reliable forms) for both men and women because ribavir...
Eligibility Criteria
Inclusion
- Written informed consent
- Treatment with peginterferon and ribavirin in the presence of a chronic Hepatitis C infection
Exclusion
- Preexisting semen abnormalities.
- Concurrent use of drugs influencing sperm concentration,motility and morphology.
- Less then one million spermatozoa/ml in semen at screening.
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00455832
Start Date
November 1 2006
End Date
July 1 2011
Last Update
February 29 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus M C, University Medical Center Rotterdam
Rotterdam, Netherlands